Dev Prasad

Stock Analyst at LUCID CAPITAL MARKETS

(n/a)
# 4,726
Out of 4,854 analysts
3
Total ratings
n/a
Success rate
-52.35%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Dev Prasad

Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $4.10
Upside: +485.37%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $0.98
Upside: +509.26%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $1.76
Upside: +638.64%